MOH
- Status: likely_approved
🇮🇱 Braftovi in Israel
Braftovi (encorafenib) regulatory status in Israel.
Marketing authorisations
MOH
- Status: likely_approved
Braftovi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Braftovi approved in Israel?
Yes. MOH has authorised it; MOH has authorised it.
Who is the marketing authorisation holder for Braftovi in Israel?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.